MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-KL-04-0002599
Medan Pharmaceuticals Private Limited
Medan Pharmaceuticals Private Limited - pharma in Payyanur, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.72 Cr
▼ 7% YoY
Net profit · FY 2025
₹9.7 Lakh
Net margin 5.6%
EBITDA · FY 2025
₹14.8 Lakh
EBITDA margin 8.6%
Authorised capital
₹31 Lakh
Registered with MCA
Paid-up capital
₹31 Lakh
Issued & subscribed
Open charges
₹72 Lakh
Secured borrowings
Company age
13 yrs
Est. 2013
Employees · EPFO
15
Provident fund records
About Medan Pharmaceuticals Private Limited
Data last updated:
Medan Pharmaceuticals Private Limited is a private limited company based in Payyanur, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 November 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U52100KL2013PTC035434. Its GSTIN is 32AAICM9866D1Z9 (Kerala).
The company has an authorised share capital of ₹31 Lakh and a paid-up capital of ₹31 Lakh. It is led by directors including Deepa Pattuvanmar Veetil (Managing Director) and Kalla Veedu Nidhin.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Raghavbhavan Pmc – 20/301 – 1 Oppositenewbusstandplot Mavicherry, Payyanur, Kerala, India – 670307.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.72 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹9.7 Lakh (net margin 5.6%) and EBITDA of ₹14.8 Lakh (EBITDA margin 8.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 5% over five years.
The company has about 15 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Medan Pharmaceuticals. As per MCA filings, the company has open charges of ₹72 Lakh on record.
Medan Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-04-0002599). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U52100KL2013PTC035434
Registration Number 035434
Incorporation Date 18 November 2013
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KL-04-0002599
Key People
Deepa Pattuvanmar Veetil Managing Director Kalla Veedu Nidhin Director Vipin Pattuvanmar Veedu Director Recognitions & Rankings of Medan Pharmaceuticals
Contact details
Medan Pharmaceuticals Private Limited's registered office is in Payyanur, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressRaghavbhavan Pmc – 20/301 – 1 Oppositenewbusstandplot Mavicherry, Payyanur, Kerala, India – 670307
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medan Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Medan Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Medan Pharmaceuticals operates one associated brand: Medan Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality finished pharmaceutical formulations. | medanpharma.com |
Business activity
The main business activity of Medan Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Medan Pharmaceuticals Private Limited, buy the company report.
Financials of Medan Pharmaceuticals Private Limited
FY 2025 filings availableMedan Pharmaceuticals Private Limited reported revenue of ₹1.72 Cr (down 7% YoY) for FY 2025.
Revenue · FY 2025
₹1.72 Cr ▼ 7%
Net profit · FY 2025
₹9.7 Lakh margin 5.6%
EBITDA · FY 2025
₹14.8 Lakh margin 8.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▲ 1%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 69%
5 years · compounded
▲ 19%
Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.8 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.6% | ||||
| Net Profit Margin | 5.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medan Pharmaceuticals Private Limited
Medan Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kalla Veedu Nidhin Also directs: Octette Pharmaceuticals Private Limited | Director | 26 Oct 2022 | 4 Years 0 Months | Current |
| Deepa Pattuvanmar Veetil Also directs: Octette Pharmaceuticals Private Limited | Managing Director | 18 Nov 2013 | 12 Years 11 Months | Current |
| Vipin Pattuvanmar Veedu | Director | 26 Oct 2022 | 4 Years 0 Months | Current |
| Arjun Thekadavan | Director | 26 Oct 2022 | 4 Years 0 Months | Current |
Auditor
Medan Pharmaceuticals Private Limited is audited by T V RANJIT & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T V RANJIT & CO. | FY 2023 | 012190S |
Shareholding
The shareholding of Medan Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medan Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹72 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Mar 2022 | 100572711 | Others | ₹45 Lakh | Open | |
| 16 Feb 2016 | 10625341 | Punjab National Bank | ₹27 Lakh | Open |
To see the full charge records of Medan Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Medan Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medan Pharmaceuticals Private Limited has a workforce of 15 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
15
Active EPFO establishments
1
GST
Medan Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAICM9866D1Z9 | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medan Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medan Pharmaceuticals Private Limited has 6 board changes on record since 2013: 4 appointments and 2 cessations. The latest: Deepa Pattuvanmar Veetil ceased to be Director on 28 Nov 2022.
AGM
Medan Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Charges
A charge with Others of Rs. 45.00 Lakh registered on 18 Mar 2022 with Charge ID 100572711 was modified on 14 Mar 2024.
Ceased
Deepa Pattuvanmar Veetil ceased to be Director.
Appointed
Arjun Thekadavan was appointed as Director.
Appointed
Kalla Veedu Nidhin was appointed as Director.
Appointed
Vipin Pattuvanmar Veedu was appointed as Director.
Ceased
Rajesh Raghavan ceased to be Director.
Charges
A charge with Others amounted to Rs. 45.00 Lakh with Charge ID 100572711 was registered on 18 Mar 2022.
Charges
A charge with Punjab National Bank amounted to Rs. 27.00 Lakh with Charge ID 10625341 was registered on 16 Feb 2016.
Appointed
Deepa Pattuvanmar Veetil was appointed as Managing Director.
Incorporation
18 Nov 2013
Medan Pharmaceuticals Private Limited was registered on 18 Nov 2013 with Roc Ernakulam & aged 12 years 11 months as per MCA records.
Frequently asked questions
Medan Pharmaceuticals is an active private limited company based in Payyanur, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 November 2013 (13+ years old) and is registered under CIN U52100KL2013PTC035434.
Medan Pharmaceuticals has 4 current directors:
- Deepa Pattuvanmar Veetil - Managing Director
- Kalla Veedu Nidhin - Director
- Vipin Pattuvanmar Veedu - Director
- Arjun Thekadavan - Director
The latest financial statements of Medan Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Medan Pharmaceuticals is 32AAICM9866D1Z9, registered in Kerala.
The CIN (Corporate Identification Number) of Medan Pharmaceuticals is U52100KL2013PTC035434. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medan Pharmaceuticals was incorporated on 18 November 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ernakulam.
Deepa Pattuvanmar Veetil ceased to be Director on 28 Nov 2022. Arjun Thekadavan was appointed as Director on 26 Oct 2022. Kalla Veedu Nidhin was appointed as Director on 26 Oct 2022. Medan Pharmaceuticals has 6 board changes on record in total.
Yes, Medan Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KL-04-0002599).
The registered office of Medan Pharmaceuticals is at Raghavbhavan Pmc – 20301 – 1 Oppositenewbusstandplot Mavicherry, Payyanur, Kerala, India – 670307.
Medan Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages